Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0002109116-26-000002·Calidi Biotherapeutics, Inc.
Schedule 13G ownership disclosure
CALIDI BIOTHERAPEUTICS INC
Common Stock, $0.0001 par value · CUSIP: 320703408
Event date: 2025-08-20
- Filing-level shares
- 560,000.00
- Percent of class
- 7.8%
- Gavrilov Ognian Anguelov
Shares: 560,000.00 · Class: 7.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002109116-26-000002
- Form type
- SCHEDULE 13G
- Filer
- Calidi Biotherapeutics, Inc.
- CIK
- CIK 1855485
- Filed
- Feb 04, 2026
- Reporting period
- Aug 20, 2025
- Description
- Schedule 13G beneficial ownership